MCPH1 Lack of Function Enhances Mitotic Cell Sensitivity Caused by Catalytic Inhibitors of Topo II

María Arroyo1, Antonio Sánchez1, Ana Cañuelo1

  • 1Department of Experimental Biology, University of Jaén, 23071 Jaén, Spain.

Genes
|April 12, 2020
PubMed

Insights

MCPH1 depletion increases cell death when Topoisomerase II (Topo II) activity is inhibited. Cells lacking MCPH1 function show heightened sensitivity to Topo II catalytic inhibition, leading to increased mitotic cell death.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Topoisomerase II (Topo II) is crucial for resolving DNA catenations, ensuring accurate chromosome segregation during mitosis.
  • A G2 checkpoint monitors Topo II activity to prevent mitotic entry until decatenation is complete.
  • MCPH1 protein, mutated in primary microcephaly, is implicated in mitotic regulation, but its role in Topo II function was unclear.

Purpose of the Study:

  • To investigate whether MCPH1 deficiency impacts Topo II activity or sensitivity during mitosis.
  • To determine if MCPH1-depleted cells exhibit altered responses to Topo II catalytic inhibition.
  • To elucidate the role of MCPH1 in maintaining mitotic fidelity under Topo II stress.

Main Methods:

  • Live single-cell imaging of MCPH1-depleted HeLa cells undergoing mitosis.
  • Catalytic inhibition of Topoisomerase II (Topo II) to perturb DNA decatenation.
  • Assessment of chromosome alignment and segregation dynamics.
  • Analysis of mitotic cell death incidence and G2 arrest abrogation via Chk1 inhibition.

Main Results:

  • MCPH1-deficient cells did not show increased susceptibility to minor decatenation defects in chromosome alignment or segregation.
  • MCPH1-depleted cells exhibited a higher incidence of mitotic cell death when Topo II activity was catalytically inhibited.
  • Abrogation of the Topo II-induced G2 arrest by Chk1 inhibition further increased mitotic cell death in MCPH1-deficient cells.

Conclusions:

  • MCPH1 deficiency does not impair the G2 decatenation checkpoint but increases mitotic hypersensitivity to Topo II catalytic inhibition.
  • The absence of MCPH1 function sensitizes cells to Topo II activity perturbations, leading to elevated mitotic cell death.
  • MCPH1 plays a critical role in cellular resilience against Topo II-mediated mitotic stress.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K